de Mestier L - Search Results

1

5-Fluorouracil biomarkers in pancreatic neuroendocrine tumours.

de Mestier L, Cros J, Hammel P. de Mestier L, et al. Pancreatology. 2017 Jul-Aug;17(4):527-528. doi: 10.1016/j.pan.2017.06.004. Epub 2017 Jun 8. Pancreatology. 2017. PMID: 28619285 No abstract available.

2

[Dramatic efficacy of chemotherapy with 5-fluorouracil and dacarbazine in a patient with metastatic glucagonoma and cardiac insufficiency].

de Mestier L, Hammel P, Hentic O, Dove P, Lévy P, Ruszniewski P. de Mestier L, et al. Gastroenterol Clin Biol. 2010 Jan;34(1):106-10. doi: 10.1016/j.gcb.2009.07.037. Epub 2009 Oct 28. Gastroenterol Clin Biol. 2010. PMID: 19875259 Free article. French.

3

[Complete resolution of insulin-dependent diabetes mellitus in a patient with autoimmune pancreatitis following treatment with corticosteroids].

de Mestier L, Dahan M, Hammel P, Hillaire S, Felce M, Penfornis A, Lévy P, Ruszniewski P. de Mestier L, et al. Gastroenterol Clin Biol. 2010 Feb;34(2):157-9. doi: 10.1016/j.gcb.2009.12.003. Epub 2010 Jan 21. Gastroenterol Clin Biol. 2010. PMID: 20096519 Free article. French.

4

Gastric juvenile polyposis with high-grade dysplasia in pachydermoperiostosis.

de Mestier L, Moreau S, Neuzillet C, Ruszniewski P, Panis Y, Hammel P. de Mestier L, et al. Case Rep Gastroenterol. 2011 Sep;5(3):508-15. doi: 10.1159/000326955. Epub 2011 Sep 3. Case Rep Gastroenterol. 2011. PMID: 22087081 Free PMC article.

5

Prolonged survival in a patient with neuroendocrine tumor of the cecum and diffuse peritoneal carcinomatosis.

de Mestier L, Neuzillet C, Hentic O, Kianmanesh R, Hammel P, Ruszniewski P. de Mestier L, et al. Case Rep Gastroenterol. 2012 Jan;6(1):205-10. doi: 10.1159/000338740. Epub 2012 Apr 30. Case Rep Gastroenterol. 2012. PMID: 22649333 Free PMC article.

6

MEK in cancer and cancer therapy.

Neuzillet C, Tijeras-Raballand A, de Mestier L, Cros J, Faivre S, Raymond E. Neuzillet C, et al. Among authors: de mestier l. Pharmacol Ther. 2014 Feb;141(2):160-71. doi: 10.1016/j.pharmthera.2013.10.001. Epub 2013 Oct 9. Pharmacol Ther. 2014. PMID: 24121058 Review.

7

Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas.

Neuzillet C, de Gramont A, Tijeras-Raballand A, de Mestier L, Cros J, Faivre S, Raymond E. Neuzillet C, et al. Among authors: de mestier l, de gramont a. Oncotarget. 2014 Jan 15;5(1):78-94. doi: 10.18632/oncotarget.1569. Oncotarget. 2014. PMID: 24393789 Free PMC article. Review.

8

Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place.

de Mestier L, Gaujoux S, Cros J, Hentic O, Vullierme MP, Couvelard A, Cadiot G, Sauvanet A, Ruszniewski P, Richard S, Hammel P. de Mestier L, et al. Ann Surg. 2015 Aug;262(2):384-8. doi: 10.1097/SLA.0000000000000856. Ann Surg. 2015. PMID: 25185468

9

Pancreatic neuroendocrine tumors in von Hippel-Lindau disease.

de Mestier L, Hammel P. de Mestier L, et al. Scand J Gastroenterol. 2015 Aug;50(8):1054-5. doi: 10.3109/00365521.2015.1022211. Epub 2015 Mar 2. Scand J Gastroenterol. 2015. PMID: 25731071 No abstract available.

10

High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis.

Neuzillet C, Couvelard A, Tijeras-Raballand A, de Mestier L, de Gramont A, Bédossa P, Paradis V, Sauvanet A, Bachet JB, Ruszniewski P, Raymond E, Hammel P, Cros J. Neuzillet C, et al. Among authors: de mestier l, de gramont a. Histopathology. 2015 Nov;67(5):664-76. doi: 10.1111/his.12691. Epub 2015 May 12. Histopathology. 2015. PMID: 25809563

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page